Gilead Sciences(us:GILD)
92.57
+1.62%
Updated on 2024-12-22
Open:90.92
Close:92.57
High:93.29
Low:90.71
Pre Close:91.09
Volume:22.53M
Amount:2.08B
Turnover:1.81%
Shares:1.25B
MarketCap:115.37B
About Gilead Sciences Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Company Name: Gilead Sciences
Company Address: 333 Lakeside Drive
Employees: 18000
Fiscar Year: 12-31
IPO Date: 1992-01-22
Website: http://www.gilead.com
CIK: 882095
View all SEC Filings
About
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Address:333 Lakeside Drive
Website:http://www.gilead.com
Market Movers